Second-line chemotherapy for refractory small cell neuroendocrine carcinoma of the esophagus that relapsed after complete remission with irinotecan plus cisplatin therapy: Case report and review of the literature

By                    

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 117-122

Spandidos Publications

Access to resources Recommend Favorite

Primary Transitional Cell Carcinoma of the Fallopian Tube: A Case Report and Review of the Literature

By Chin H.   Matsui H.   Mitsuhashi A.   Nagao K.   Sekiya S.  

Gynecologic Oncology, Vol. 71, Iss. 3, 1998-12 ,pp. : 469-475

Elsevier

Access to resources Recommend Favorite

Pegylated liposomal doxorubicin for platinum-resistant or refractory Müllerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of Fallopian tube and peritoneal carcinoma): A single-institutional experience

By                    

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 35-38

Spandidos Publications

Access to resources Recommend Favorite

Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, fallopian tube cancer, and primary carcinoma of the peritoneum

By Markman M.   Zanotti K.   Webster K.   Peterson G.   Kulp B.   Belinson J.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 573-576

Elsevier

Access to resources Recommend Favorite

Phase 2 Trial of Liposomal Doxorubicin (40 mg/m 2 ) in Platinum/Paclitaxel-Refractory Ovarian and Fallopian Tube Cancers and Primary Carcinoma of the Peritoneum

By Markman M.   Kennedy A.   Webster K.   Peterson G.   Kulp B.   Belinson J.  

Gynecologic Oncology, Vol. 78, Iss. 3, 2000-09 ,pp. : 369-372

Elsevier

Access to resources Recommend Favorite